YD Bio Ltd (YDES) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN KYG983011076
YD Bio Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 510,360.00 USD | 596,817.00 USD |
| Gross profit | 155,356.00 USD | -42,149.00 USD |
| Operating income | -1.46 m USD | -5.27 m USD |
| EBIT | -1.39 m USD | -8.31 m USD |
| Net income | -1.41 m USD | -8.31 m USD |
| Diluted EPS – continuing operations | -0.34 USD | -0.12 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About YD Bio Ltd
YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate symptoms of dry eye syndrome, including irritation, foreign body sensation, and eye fatigue; and LSC Eye Drug/Injection, an injectable ophthalmic drug is being developed for the treatment of various retinal and macular disorders, such as age-related macular degeneration, macular edema, choroidal and subretinal neovascularization, and neovascular glaucoma. It also provides Hydrogel (Hioxifilcon A) Soft (Hydrophilic) Contact Lens, a spherical and aspherical lenses. In addition, the company supplies drugs and medical materials for clinical trials; and operates DNA methylation-based oncology testing programs. Further, it provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination, and compliance-focused support for clinical development programs to pharmaceutical and biotechnology companies. It serves corporate and retail customers. The company was founded in 2013 and is based in Taipei, Taiwan.
More stocks
- Qingdao Richen Food Co Ltd (603755.SS)
- ROCKY BRANDS, INC. (RCKY)
- Harbin Sayyas Windows Co. Ltd. A (301227.SZ)
- M1 Kliniken (M12.DE)
- Hangzhou Tianyuan Pet Products Co. Ltd. A (301335.SZ)
- Guangdong Guanghong Holdings Co Ltd (000529.SZ)
- Trastor Real Estate Investment Company SA (TRASTOR.AT)
- BizConf Telecom Co Ltd (300578.SZ)
- Changzhou Langbo Seal Polytron Technologies Co Ltd Class A (603655.SS)
- IEI Integration Corp (3022.TW)
- TECSYS Inc. (TCS.TO)
- Shanghai Xuerong Bio-Technology Co Ltd (300511.SZ)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.